Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,101,295
-
Share change
-
+175,695
-
Total reported value
-
$2,184,000
-
Put/Call ratio
-
120%
-
Price per share
-
$1.04
-
Number of holders
-
20
-
Value change
-
+$269,274
-
Number of buys
-
11
-
Number of sells
-
9
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2020
As of 30 Sep 2020,
IGC Pharma, Inc. - COM NEW (IGC) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,101,295 shares.
The largest 10 holders included
Carroll Financial Associates, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, DEARBORN PARTNERS LLC, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, and TRUIST FINANCIAL CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.